Evans Daron's most recent trade in Rezolute Inc was a trade of 5,000 Common Shares done at an average price of $4.1 . Disclosure was reported to the exchange on June 24, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rezolute Inc | Daron Evans | CFO | Purchase of securities on an exchange or from another person at price $ 4.05 per share. | 24 Jun 2025 | 5,000 | 268,900 | - | 4.1 | 20,250 | Common Shares |
| Rezolute Inc | Daron Evans | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 26,000 | 263,900 | - | 0 | Common Shares | |
| Rezolute Inc | Daron Evans | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 15,000 | 15,000 | - | - | Employee Stock Option (Right to Buy) | |
| Rezolute Inc | Daron Evans | CFO | Purchase of securities on an exchange or from another person at price $ 2.89 per share. | 26 Mar 2025 | 10,000 | 237,900 | - | 2.9 | 28,900 | Common Shares |
| Rezolute Inc | Daron Evans | CFO | Purchase of securities on an exchange or from another person at price $ 2.88 per share. | 26 Mar 2025 | 10,000 | 23,000 | - | 2.9 | 28,800 | Common Shares |
| Rezolute Inc | Daron Evans | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2025 | 77,000 | 227,900 | - | 0 | Common Shares | |
| Rezolute Inc | Daron Evans | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2025 | 45,000 | 45,000 | - | - | Employee Stock Option (Right to Buy) | |
| Rezolute Inc | Daron Evans | CFO | Purchase of securities on an exchange or from another person at price $ 4.29 per share. | 18 Dec 2024 | 10,000 | 150,900 | - | 4.3 | 42,900 | Common Shares |
| Rezolute Inc | Evans Daron | CFO | Purchase of securities on an exchange or from another person at price $ 4.60 per share. | 12 Dec 2024 | 9,000 | 140,900 | - | 4.6 | 41,400 | Common Shares |
| Rezolute Inc | Daron Evans | CFO | Purchase of securities on an exchange or from another person at price $ 5.04 per share. | 09 Dec 2024 | 10,549 | 131,900 | - | 5.0 | 53,167 | Common Shares |
| Rezolute Inc | Daron Evans | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2024 | 100,000 | 100,000 | - | - | Employee Stock Option (Right to Buy) | |
| Rezolute Inc | Daron Evans | CFO | Purchase of securities on an exchange or from another person at price $ 4.04 per share. | 14 Jun 2024 | 40,000 | 40,000 | - | 4.0 | 161,568 | Common Shares |
| Rezolute Inc | Daron Evans | CFO | Purchase of securities on an exchange or from another person at price $ 3.50 per share. | 29 May 2024 | 451 | 121,351 | - | 3.5 | 1,579 | Common Shares |
| Rezolute Inc | Daron Evans | CFO | Purchase of securities on an exchange or from another person at price $ 3.23 per share. | 23 May 2024 | 2,942 | 13,000 | - | 3.2 | 9,503 | Common Shares |
| Rezolute Inc | Daron Evans | CFO | Purchase of securities on an exchange or from another person at price $ 2.84 per share. | 23 May 2024 | 58 | 10,058 | - | 2.8 | 165 | Common Shares |
| Rezolute Inc | Daron Evans | CFO | Purchase of securities on an exchange or from another person at price $ 1.69 per share. | 15 Mar 2024 | 20,000 | 20,000 | - | 1.7 | 33,830 | Common Shares |
| Rezolute Inc | Daron Evans | CFO | Purchase of securities on an exchange or from another person at price $ 1.93 per share. | 08 Mar 2024 | 50,000 | 120,900 | - | 1.9 | 96,345 | Common Shares |
| Rezolute Inc | Evans Daron | CFO | Purchase of securities on an exchange or from another person at price $ 1.30 per share. | 16 Feb 2024 | 41,900 | 70,900 | - | 1.3 | 54,411 | Common Shares |
| Rezolute Inc | Evans Daron | CFO | Purchase of securities on an exchange or from another person at price $ 1.37 per share. | 16 Feb 2024 | 4,500 | 4,500 | - | 1.4 | 6,165 | Common Shares |
| Rezolute Inc | Daron Evans | CFO | Purchase of securities on an exchange or from another person at price $ 1.37 per share. | 16 Feb 2024 | 4,500 | 4,500 | - | 1.4 | 6,165 | Common Shares |
| Rezolute Inc | Evans Daron | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 275,000 | 275,000 | - | - | Employee Stock Option (Right to Buy) | |
| Nephros Inc | Daron Evans | CEO Specialty Renal Products | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.70 per share. | 24 May 2021 | 349 | 8,669 (0%) | 0% | 2.7 | 942 | Common Stock |
| Nephros Inc | Daron Evans | CEO Specialty Renal Products | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.70 per share. | 24 May 2021 | 349 | 8,947 (0%) | 0% | 2.7 | 942 | Common Stock |